References
- DeSantisCELinCCMariottoABCancer treatment and survivorship statistics, 2014CA Cancer J Clin201464425227124890451
- SiegelRMaJZouZJemalACancer statistics, 2014CA Cancer J Clin201464192924399786
- ZarogoulidisPPatakaATerziEIntensive care unit and lung cancer: when should we intubate?J Thorac Dis20135Suppl 4S407S41224102014
- KrennLKoppBBufadienolides from animal and plant sourcesPhytochemistry19984811299621450
- QiFLiAInagakiYAntitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans CantorInt Immunopharmacol201111334234921185919
- LuCXNanKJLeiYAgents from amphibians with anticancer propertiesAnticancer Drugs2008191093193918827558
- CuiXInagakiYXuHAnti-hepatitis B virus activities of cinobufacini and its active components bufalin and cinobufagin in HepG2.2.15 cellsBiol Pharm Bull201033101728173220930383
- KangXHZhangJHZhangQQDegradation of Mcl-1 through GSK-3β Activation Regulates Apoptosis Induced by Bufalin in Non-Small Cell Lung Cancer H1975 CellsCell Physiol Biochem20174152067207628419994
- MiaoQBiLLLiXAnticancer effects of bufalin on human hepatocellular carcinoma HepG2 cells: roles of apoptosis and autophagyInt J Mol Sci20131411370138223344047
- XieCMChanWYYuSZhaoJChengCHBufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activationFree Radic Biol Med20115171365137521763418
- AmanoYChoYMatsunawaMKomiyamaKMakishimaMIncreased nuclear expression and transactivation of vitamin D receptor by the cardiotonic steroid bufalin in human myeloid leukemia cellsJ Steroid Biochem Mol Biol20091143–514415119429444
- LiDQuXHouKPI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cellsAnticancer Drugs2009201596419343001
- ShenSZhangYWangZLiuRGongXBufalin induces the interplay between apoptosis and autophagy in glioma cells through endoplasmic reticulum stressInt J Biol Sci201410221222424550689
- TsaiSCYangJSPengSFBufalin increases sensitivity to AKT/mTOR-induced autophagic cell death in SK-HEP-1 human hepatocellular carcinoma cellsInt J Oncol20124141431144222858649
- ChenYYLuHFHsuSCBufalin inhibits migration and invasion in human hepatocellular carcinoma SK-Hep1 cells through the inhibitions of NF-kB and matrix metalloproteinase-2/-9-signaling pathwaysEnviron Toxicol2015301748223949904
- HuQLiangBSunYPreparation of bufalin-loaded pluronic polyetherimide nanoparticles, cellular uptake, distribution, and effect on colorectal cancerInt J Nanomedicine2014914035404125187707
- KimSSRaitARubabFThe clinical potential of targeted nanomedicine: delivering to cancer stem-like cellsMol Ther201422227829124113515
- LiMZhangWWangBGaoYSongZZhengQCLigand-based targeted therapy: a novel strategy for hepatocellular carcinomaInt J Nanomedicine2016115645566927920520
- ZhaoRMatherlyLHGoldmanIDMembrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissuesExpert Rev Mol Med200911e419173758
- O’ShannessyDJYuGSmaleRFolate receptor alpha expression in lung cancer: diagnostic and prognostic significanceOncotarget20123441442522547449
- AssarafYGLeamonCPReddyJAThe folate receptor as a rational therapeutic target for personalized cancer treatmentDrug Resist Updat2014174–6899525457975
- SiafakaPBetsiouMTsolouASynthesis of folate-pegylated polyester nanoparticles encapsulating ixabepilone for targeting folate receptor overexpressing breast cancer cellsJ Mater Sci Mater Med2015261227526543021
- DanielsTRBernabeuERodríguezJAThe transferrin receptor and the targeted delivery of therapeutic agents against cancerBiochim Biophys Acta20121820329131721851850
- KoshkaryevAPiroyanATorchilinVPIncreased apoptosis in cancer cells in vitro and in vivo by ceramides in transferrin-modified liposomesCancer Biol Ther2012131506022336588
- SapraPAllenTMImproved outcome when B-cell lymphoma is treated with combinations of immunoliposomal anticancer drugs targeted to both the CD19 and CD20 epitopesClin Cancer Res20041072530253715073133
- HareJIMoaseEHAllenTMTargeting combinations of liposomal drugs to both tumor vasculature cells and tumor cells for the treatment of HER2-positive breast cancerJ Drug Target2013211879623039213
- SriramanSKSalzanoGSarisozenCTorchilinVAnti-cancer activity of doxorubicin-loaded liposomes co-modified with transferrin and folic acidEur J Pharm Biopharm2016105404927264717
- GaoJQLvQLiLMGlioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomesBiomaterials201334225628563923628475
- KolhatkarRLoteAKhambatiHActive tumor targeting of nanomaterials using folic acid, transferrin and integrin receptorsCurr Drug Discov Technol20118319720621696360
- YuanFDellianMFukumuraDVascular permeability in a human tumor xenograft: molecular size dependence and cutoff sizeCancer Res19955517375237567641188
- SahayGAlakhovaDYKabanovAVEndocytosis of nanomedicinesJ Control Release2010145318219520226220
- PaulosCMReddyJALeamonCPTurkMJLowPSLigand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug deliveryMol Pharmacol20046661406141415371560